Increased levels of thymidylate synthetase in cells exposed to 5- fluorouracil

WL Washtien

The binding of 5-fluoro-2'-deoxyuridylate, methylenetetrahydrofolate, and thymidylate synthetase in a ternary complex results in enzyme inhibition and is a major component of 5-fluorouracil cytotoxicity in some cells. The amount of 5-fluoro-2'-deoxyuridylate bound to thymidylate synthetase in several human gastrointestinal tumor cell lines following 5-fluorouracil exposure was determined, using Sephadex G-25 chromatography and high-pressure chromatographic analysis. These data were compared with previously determined values for thymidylate synthetase levels in control cultures not exposed to 5-fluorouracil. In HuTu 80 cells, the amount of 5-fluoro-2'-deoxyuridylate bound to thymidylate synthetase represented 16% of the total amount of enzyme present in untreated cells. The values for 5-fluoro-2'-deoxyuridylate bound to thymidylate synthetase in the WIDR and HT 29 cell lines (57 and 46 fmoles/10(5) cells, respectively), however, exceed by 3- to 6- fold the total amount of this enzyme found in untreated cells. The presence of increased levels of thymidylate synthetase protein in these cell lines was confirmed by sodium dodecyl sulfate gel electrophoresis. Measurements of thymidylate synthetase levels following exposure of cells to cycloheximide demonstrated that thymidylate synthetase complexed to 5-fluoro-2'-deoxyuridylate has increased stability as compared with uncomplexed enzyme. The level of thymidylate synthetase (bound and free) present in WIDR cells was measured following removal of FUra from the media. After 48 hr, the level of bound enzyme had fallen from 53 to 14 fmoles/10(5) cells, whereas free enzyme, which was undetectable after a 24-hr exposure to FUra, returned to 60% of its level in untreated cells.

Volume 25, Issue 1, pp. 171-177, 01/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				T. Okabe, I. Okamoto, S. Tsukioka, J. Uchida, T. Iwasa, T. Yoshida, E. Hatashita, Y. Yamada, T. Satoh, K. Tamura, et al. Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase Mol. Cancer Ther., March 1, 2008; 7(3): 599 - 606. [Abstract] [Full Text] [PDF]

				P. G. Johnston, A. B. Benson III, P. Catalano, M. S. Rao, P. J. O'Dwyer, and C. J. Allegra Thymidylate Synthase Protein Expression in Primary Colorectal Cancer: Lack of Correlation With Outcome and Response to Fluorouracil in Metastatic Disease Sites J. Clin. Oncol., March 1, 2003; 21(5): 815 - 819. [Abstract] [Full Text] [PDF]

				C. Aschele, D. Debernardis, R. Bandelloni, S. Cascinu, V. Catalano, P. Giordani, S. Barni, D. Turci, G. Drudi, S. Lonardi, et al. Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil Ann. Onc., December 1, 2002; 13(12): 1882 - 1892. [Abstract] [Full Text] [PDF]

				D. B. Longley, P. R. Ferguson, J. Boyer, T. Latif, M. Lynch, P. Maxwell, D. P. Harkin, and P. G. Johnston Characterization of a Thymidylate Synthase (TS)-inducible Cell Line: A Model System for Studying Sensitivity to TS- and non-TS-targeted Chemotherapies Clin. Cancer Res., November 1, 2001; 7(11): 3533 - 3539. [Abstract] [Full Text] [PDF]

				C. Aschele, D. Debernardis, G. Tunesi, F. Maley, and A. Sobrero Thymidylate Synthase Protein Expression in Primary Colorectal Cancer Compared with the Corresponding Distant Metastases and Relationship with the Clinical Response to 5-Fluorouracil Clin. Cancer Res., December 1, 2000; 6(12): 4797 - 4802. [Abstract] [Full Text]

				S. J. Welsh, J. Titley, L. Brunton, M. Valenti, P. Monaghan, A. L. Jackman, and G. W. Aherne Comparison of Thymidylate Synthase (TS) Protein Up-Regulation after Exposure to TS Inhibitors in Normal and Tumor Cell Lines and Tissues Clin. Cancer Res., June 1, 2000; 6(6): 2538 - 2546. [Abstract] [Full Text]

				X. Lin, L. A. Parsels, D. M. Voeller, C. J. Allegra, G. F. Maley, F. Maley, and E. Chu Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA Nucleic Acids Res., March 15, 2000; 28(6): 1381 - 1389. [Abstract] [Full Text] [PDF]

				M. E. Kitchens, A. M. Forsthoefel, Z. Rafique, H. T. Spencer, and F. G. Berger Ligand-mediated Induction of Thymidylate Synthase Occurs by Enzyme Stabilization. IMPLICATIONS FOR AUTOREGULATION OF TRANSLATION J. Biol. Chem., April 30, 1999; 274(18): 12544 - 12547. [Abstract] [Full Text] [PDF]

				E. Chu, J. L. Grem, P. G. Johnston, and C. J. Allegra New Concepts for the Development and Use of Antifolates Oncologist, August 1, 1996; 1(4): 255 - 259. [Abstract] [Full Text] [PDF]

				E Chu, J. Grem, P. Johnston, and C. Allegra New concepts for the development and use of antifolates Stem Cells, January 1, 1996; 14(1): 41 - 46. [Abstract]